News
Research and development expenses were $25.8 million for the quarter ended March 31, 2025, compared to $11.7 million for the ...
Cedars-Sinai researchers have developed a novel nutritional formula, mBiota Elemental, a palatable elemental diet (PED) that ...
A global clinical trial is underway to evaluate two anti-inflammatory drugs as potential treatments for long COVID, aiming to ...
Six ways clinical trial facilitators can address implicit bias against Black Americans and increase Black enrollment.
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland ...
13d
GlobalData on MSNLokavant launches Spectrum v15 trial forecasting solutionLokavant has launched the AI-powered clinical trial forecasting solution, Spectrum v15, to dispel uncertainty in the ...
12d
News Medical on MSNGlobal clinical trial to test existing drugs as long COVID treatmentsSpanning four continents and enrolling hundreds of people, a new clinical trial will test the effectiveness of two ...
FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...
Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...
The average number of industry-funded trials started per month was 135.8 before the IRA was passed and 83.6 after — a 38.4% decrease.
Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results
Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results